相关实验视频

Updated: Jun 29, 2025

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

医疗器械监管在血管衰老评估:一个VascAgeNet调查探索知识和感知

Maria Raffaella Martina¹, Chloe Park², Jordi Alastruey³

¹Institute of Clinical Physiology - Italian National Research Council (CNR-IFC), Pisa, Italy.

Expert review of medical devices

|April 1, 2024

概括

血管衰老评估的利益相关者对欧盟医疗器械条例 (MDR) 有相当的了解,但希望得到更多的支持. 改善监管科学培训和机构支持对于有效实施医疗器械至关重要.

科学领域:

医疗器械规则医疗器械规则
血管衰老评估的评估
监管科学监管科学

背景情况:

欧盟医疗器械条例 (MDR) 影响所有医疗器械,包括用于血管衰老的医疗器械.
了解利益相关者的需求是临床实践中MDR实施的关键.
本研究探讨了在血管衰老领域对医疗器械监管框架的看法.

研究的目的:

评估血管衰老的利益相关者对医疗器械监管框架的知识和看法.
确定在这个特定领域有效实施MDR的需求.

主要方法:

一项调查由VascAgeNet开发,并使用EUSurvey平台分发.
从94名参与者收集的数据,包括临床医生,研究人员和公司.

主要成果:

大多数参与者对MDR有相当的了解,尽管51%的人自我评估他们的知识很差.
安全性,验证和风险管理被确定为关键的监管问题.
许多人报告说,缺乏机构支持和专门的监管部门.

结论:

VascAgeNet社区认识到医疗器械监管的重要性.
显然需要加强医疗器械监管科学方面的支持和培训.
改善对监管专业知识的直接访问对于临床翻译至关重要.

关键词:

在MDR中使用MDR.医疗器械医疗器械医疗器械监管监管监管监管监管监管调查调查调查调查调查调查调查调查血管衰老血管衰老血管衰老

更多相关视频

Non-invasive Assessment of Microvascular and Endothelial Function

Non-invasive Assessment of Microvascular and Endothelial Function

Published on: January 29, 2013

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Assessment of the Cardiovascular System I: Subjective Data

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...